Skip to content
2000
image of The Protective Role of Haplotype -607A/-137C in the Promoter Region of IL-18 Gene and HBV Infection Risk in the North Indian Population

Abstract

Introduction

One of the most dangerous illnesses in the world today is hepatitis B virus (HBV) infection, which mainly affects the liver and can cause cirrhosis, hepatocellular carcinoma (HCC), and chronic infection. The primary goal of this study was to determine whether genotype polymorphisms at particular locations of the IL-18 promoter region may affect the host susceptibility to HBV infection in the North Indian population.

Methods

Genetic polymorphism of the IL-18 gene in the promoter region at positions -607 and -137 was performed in the North Indian population (100 controls and 100 HBV patients) using the PCR-RFLP method. Genotypic, allelic, and haplotype frequencies were compared using SHEsis software.

Results

There were no significant differences in individual genotype or allele frequencies at positions -607 and -137 between HBV patients and controls. However, there were statistically significant differences with high frequencies of the -607A/-137C haplotype in HBV patients (p=0.010), whereas the -607C/-137C haplotype was more prevalent in controls (p=0.001), indicating a protective effect.

Discussion

The individual SNPs did not show significant association, but specific haplotypes of the IL-18 promoter region may influence the risk of HBV infection. These results align partially with previous studies and suggest that haplotype-based analysis provides improved insight into genetic susceptibility.

Conclusion

The present study indicates that a double mutation (polymorphism) -607A/-137C in the IL-18 gene promoter region may contribute to the onset of HBV infection, while a single nucleotide polymorphism (-607C/-137C) may provide less susceptibility to HBV and may have a protective impact.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073377295250911070504
2025-10-31
2025-11-07

  • From This Site

    /content/journals/cchts/10.2174/0113862073377295250911070504
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Chen G.F. Wang C. Lau G. Treatment of chronic hepatitis B infection‐2017. Liver Int. 2017 37 S1 59 66 (Suppl. 1) 10.1111/liv.13309 28052634
    [Google Scholar]
  2. Hepatitis B. 2024 Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
  3. 2022 Available from: https://www.who.int/india/health-topics/hepatitis
  4. Hepatitis B. Hepatitis B (HepB3) immunization coverage among 1-year-olds (%). Available from 2022 [https://www.who.int/data/gho/data/indicators/indicator-details/GHO/hepatitis-b-(hepb3)-immunization-coverage-among-1-year-olds-(-)
    [Google Scholar]
  5. Ray G. Functional cure of chronic hepatitis B-hope or hype? World J. Hepatol. 2024 16 9 1199 1205 10.4254/wjh.v16.i9.1199 39351521
    [Google Scholar]
  6. Zhang Z. Wang C. Liu Z. Host genetic determinants of hepatitis B virus infection. Front. Genet. 2019 10 696 10.3389/fgene.2019.00696 31475028
    [Google Scholar]
  7. Zeng Z. Human genes involved in hepatitis B virus infection. World J. Gastroenterol. 2014 20 24 7696 7706 10.3748/wjg.v20.i24.7696 24976707
    [Google Scholar]
  8. Motavaf M. Safari S. Alavian S.M. Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: A review study. Hepat. Mon. 2014 14 5 e19879 10.5812/hepatmon.19879 25031585
    [Google Scholar]
  9. Florian P. Lazar C. Nichita N. Galantonu R. Popescu C. Ruta S. Roseanu A. Coumarin labeling of hepatitis B virus. J. Viral Hepat. 2015 22 S3 39 49
    [Google Scholar]
  10. Guidotti L.G. Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 2001 19 1 65 91 10.1146/annurev.immunol.19.1.65 11244031
    [Google Scholar]
  11. Rapicetta M. Ferrari C. Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J. Med. Virol. 2002 67 3 454 457 10.1002/jmv.10096 12116045
    [Google Scholar]
  12. Nakanishi K. Unique action of interleukin-18 on T cells and other immune cells. Front. Immunol. 2018 9 763 10.3389/fimmu.2018.00763 29731751
    [Google Scholar]
  13. McInnes I.B. Gracie J.A. Leung B.P. Wei X.Q. Liew F.Y. Interleukin 18: A pleiotropic participant in chronic inflammation. Immunol. Today 2000 21 7 312 315 10.1016/S0167‑5699(00)01648‑0 10871869
    [Google Scholar]
  14. Kalina U. Ballas K. Koyama N. Kauschat D. Miething C. Arnemann J. Martin H. Hoelzer D. Ottmann O.G. Genomic organization and regulation of the human interleukin-18 gene. Scand. J. Immunol. 2000 52 6 525 530 10.1111/j.1365‑3083.2000.00836.x 11119255
    [Google Scholar]
  15. Kimura K. Kakimi K. Wieland S. Guidotti L.G. Chisari F.V. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J. Virol. 2002 76 21 10702 10707 10.1128/JVI.76.21.10702‑10707.2002 12368312
    [Google Scholar]
  16. Zhang P.A. Wu J.M. Li Y. Yang X.S. Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population. World J. Gastroenterol. 2005 11 11 1594 1598 10.3748/wjg.v11.i11.1594 15786533
    [Google Scholar]
  17. Li Z. Zhang Z. He Z. Tang W. Li T. Zeng Z. He L. Shi Y. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: Update of the SHEsis ([http://analysis.bio-x.cn). Cell Res. 2009 19 4 519 523 10.1038/cr.2009.33 19290020
    [Google Scholar]
  18. Hirankarn N. Manonom C. Tangkijvanich P. Poovorawan Y. Association of interleukin‐18 gene polymorphism (−607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Tissue Antigens 2007 70 2 160 163 10.1111/j.1399‑0039.2007.00865.x 17610422
    [Google Scholar]
  19. Li N. Gao Y.F. Zhang T.C. Chen P. Li X. Su F. Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J. Hepatol. 2012 4 3 105 109 10.4254/wjh.v4.i3.105 22489263
    [Google Scholar]
  20. Karra V.K. Gumma P.K. Chowdhury S.J. Ruttala R. Polipalli S.K. Chakravarti A. Kar P. IL-18 polymorphisms in hepatitis B virus related liver disease. Cytokine 2015 73 2 277 282 10.1016/j.cyto.2015.02.015 25802197
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073377295250911070504
Loading
The Protective Role of Haplotype -607A/-137C in the Promoter Region of IL-18 Gene and HBV Infection Risk in the North Indian Population
Bentham Science Publishers ; https://doi.org/10.2174/0113862073377295250911070504
/content/journals/cchts/10.2174/0113862073377295250911070504
/content/journals/cchts/10.2174/0113862073377295250911070504
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Interferon-γ (IFN-γ) inducing factor ; single nucleotide polymorphism ; hepatitis B virus ; cytokines ; IL-18 ; genetic polymorphism

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test